China rushes to develop Moderna-style cancer vaccines amid market frenzy

A group of Hong Kong-listed biotechnology companies have seen their stock prices surge in the wake of Moderna’s breakthrough cancer vaccine trial, as the Chinese companies push forward with similar vaccine programmes. The companies – from Jiangsu Hengrui Pharmaceuticals to Li Ka-shing-backed CK Life Sciences – already

Democratic senators said RFK Jr.'s recent explanation of how he disposed of a financial stake in Gardasil litigation conflicts with his earlier answers

It is the first time that an mRNA-based cancer vaccine has succeeded in a large-scale study.

Hype for Moderna’s Cancer Vaccine Is Running Ahead of the Math  WSJ